127 results
Page 2 of 7
6-K
EX-99.1
rwnjqhj0 q4p
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.3
860ygwejhgcefzcsjboj
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
62xu 57ym
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
s395297pxjkh8gg5p z4
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
o48cyk1
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.1
i50622
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
9vrs3ttbru1kfq2ciq
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
kn2wgtxrmlv8etg86v
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.2
yond n02fhmg4
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
qo4 fo5il
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
6-K
EX-99.2
0l45 ywceux
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
25iyd81jvzj6x3
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
13xe74pqmer8 wvu2pds
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
xf9 d8mtz0edt0se3
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
raaw28vtsa ay0so0
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
xipwgauhw 1g6
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm